End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.27 CNY | -0.32% | +4.04% | -21.90% |
Apr. 26 | Tibet AIM Pharm. Inc. Proposes Final Cash Dividend for 2023 | CI |
Apr. 25 | Tibet AIM Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2022 | 857M 119M | Sales 2023 | 667M 92.32M | Capitalization | 2.26B 313M |
---|---|---|---|---|---|
Net income 2022 | 44M 6.09M | Net income 2023 | 15M 2.08M | EV / Sales 2022 | 1.95 x |
Net cash position 2022 | 271M 37.54M | Net cash position 2023 | 375M 51.88M | EV / Sales 2023 | 2.83 x |
P/E ratio 2022 |
44.3
x | P/E ratio 2023 |
148
x | Employees | 447 |
Yield 2022 |
0.98% | Yield 2023 |
-
| Free-Float | 62.16% |
1 day | +1.20% | ||
1 week | +4.38% | ||
Current month | +4.38% | ||
1 month | +4.73% | ||
3 months | +50.49% | ||
6 months | -22.18% | ||
Current year | -21.65% |
Managers | Title | Age | Since |
---|---|---|---|
Ke Xu
CEO | Chief Executive Officer | 46 | 09-12-31 |
Min Zhou
DFI | Director of Finance/CFO | 37 | 23-01-31 |
Ling Li
CHM | Chairman | 55 | 20-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ming Hu
BRD | Director/Board Member | 53 | 21-09-12 |
Zhan Zhou
BRD | Director/Board Member | 55 | 14-12-11 |
Qian Jin Li
IRC | Investor Relations Contact | 47 | 04-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 9.27 | -0.32% | 6 138 900 |
24-05-07 | 9.3 | +1.20% | 7,308,400 |
24-05-06 | 9.19 | +3.14% | 7,842,100 |
24-04-30 | 8.91 | +0.34% | 6,748,000 |
End-of-day quote Shenzhen S.E., May 06, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-21.65% | 246M | |
+33.43% | 700B | |
+27.66% | 569B | |
-5.12% | 358B | |
+19.59% | 330B | |
+4.89% | 287B | |
+15.91% | 236B | |
+6.70% | 202B | |
-9.41% | 197B | |
+4.26% | 161B |
- Stock Market
- Equities
- 002826 Stock